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Abstract 
Electrochemical aptasensor arrays have been recently used to detect several proteins 
reported as disease biomarkers, mainly due to their known advantages, that include high 
affinity, sensitivity, specificity and low costs, among others. This study describes the 
development of a label-free electrochemical multi-aptasensor array, for the 
simultaneous detection of human osteopontin (OPN), using two specific aptamers. To 
enable multiplexed protein assay, RNA and DNA aptamers were immobilized in the 
dual-screen-printed gold working electrodes via streptavidin-biotin interaction, and 
using the [Fe(CN)6]3−/4− as the redox probe for cyclic voltammetry measurements. The 
multi-aptasensor array herein developed exhibited a good response and selectivity to 
detect human OPN in the presence of other interfering proteins.  
Considering these preliminary results, the DNA/RNA dual aptasensor array could 
potentially be used as an analytical tool for the specific detection of human OPN, and 
for cancer diagnosis overall. 
 
Keywords: Aptasensor array, electrochemical detection, osteopontin, aptamer, dual-
screen-printed gold electrode. 
 
 
Introduction 
The simultaneous detection of multiple proteins or the multiple detection of a 
specific protein in a single assay, by using biosensor devices with several 
working electrodes (WE), open new promising possibilities regarding the design 
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of new and personalized approaches that may be used for the early detection and 
therapy of many diseases, e.g. cancer [1–3]. Most cancer diseases are associated 
with the presence of several biomarkers, such as proteins that could be used as 
potential diagnostic or prognostic markers, indicative of the disease stages [4, 5]. 
Osteopontin (OPN) is a phosphorylated glycoprotein that has been reported as a 
potential breast cancer biomarker. Indeed, its over expression may be indicative 
of tumour formation, cancer progression, metastasis and poor prognosis [6–9]. 
To improve the survival of patients with cancer diseases, their early diagnosis is 
crucial. Therefore, it is necessary to develop new, simple and cost-effective 
methods for the detection and quantification of these protein biomarkers. The 
aptasensor arrays could be an effective alternative to conventional analytical 
methods, considering their known advantages, such as the possibility of 
simultaneous multiple detection of proteins in a single assay, the reduction of the 
sample and reagents’ volumes, and of the  analysis’ costs, and the possibility to 
perform several replicates per assay [3, 10–12]. The development of aptasensors 
arrays requires the design of screen-printed electrodes (SPE) with several 
working electrodes, and the selection of aptamers in similar experimental 
conditions (e.g. pH, temperature, length of the sequence, ionic changes, among 
others), aiming to minimize the risk of affecting their high affinity and specificity 
towards the target molecule [10,11].  
The simultaneous detection of multiple protein biomarkers using multi-electrodes 
arrays based on immunosensors has been reported in the literature [13,14]. In the 
last years, the use of electrode arrays to develop novel electrochemical 
aptasensor devices has gained popularity. Song et al. [4] described an 
electrochemical aptasensor array for the multiplexed detection of platelet-derived 
growth factor-BB (PDGF-BB) and thrombin using a SPE array with four 
subarrays, four independent carbon working electrodes (WE) and one counter 
electrode (CE). The proposed aptasensor array allowed multi-detection with good 
selectivity, showing both PDGF-BB and thrombin (THR) aptamer-modified 
electrodes only stripping responses against their respective proteins. Moreover, 
no cross-reaction between the two aptamers towards non-cognate proteins was 
reported. Liu et al. [15] described an electrochemical aptasensor array for the 
detection of interferon gamma (IFN-γ) and tumour necrosis factor alpha (TNF-α), 
using micropatterned aptamer-modified gold electrodes. The developed 
aptasensor array showed similar sensitivity to that of the single aptasensors for 
both proteins, and it was found to be applicable for the detection of those proteins 
in activated T cells and monocytes cell lines. Recently, the same research group 
[16] reported an electrochemical aptasensor for the specific detection of multiple 
cytokines (IFN-γ and TNF-α), using an electrode-array with a set of four 
miniaturized WE. The aptasensor showed high specificity and sensitivity, 
similarly to that of the single analyte aptasensor, for each biomarker.  
This work describes the development of an electrochemical aptasensor array 
using two specific aptamers for the simultaneous detection of human OPN. 
Although aptasensors are usually used for the multiplex analysis of different 
proteins, they can also be used to increase the sensitivity of detection of a single 
protein. Thus, in the current work, two different aptamers were used to detect and 
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quantify OPN. For that purpose, a dual-screen-printed gold electrode (dual-
SPGE) was used.  
 
 
Materials and methods 
Reagents and apparatus 
Diethylpyrocarbonate (DEPC), 3,3-dithiodipropionic acid (DPA), N-(3-
dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC), N-
hydroxysuccinimide (NHS), ethanolamine (ETA) and sulfuric acid (purity of 
99.999 %) were obtained from Sigma-Aldrich. Potassium hexacyanoferrate (III) 
(K3Fe(CN)6) and potassium hexacyanoferrate (II) (K4Fe(CN)6) were obtained 
from Acros Organics, and potassium dihydrogen phosphate (KH2PO4) from 
Merck. Sodium chloride (NaCl), potassium chloride (KCl) and sodium hydrogen 
phosphate (Na2HPO4) were acquired from Panreac. All chemicals were of 
analytical grade and used as received. All proteins were acquired under a 
lyophilized form, and prepared according to the manufacturer specifications. The 
stock solutions of each protein were stored at -20 ºC. The protein working 
solutions were obtained by dilution of the stock solutions with phosphate buffer 
saline (PBS) (pH 7.4), and were stored at 4 ºC until use. Recombinant human 
OPN (rhOPN, 65 kDa) and recombinant bovine OPN (rbOPN, 60 kDa) were 
purchased from R&D Systems. Thrombin from human plasma (THR, 37.4 kDa), 
bovine serum albumin (BSA, 66 kDa), lysozyme from chicken egg whites (LYS, 
14.3 kDa) and streptavidin were obtained from Sigma-Aldrich.  
 
 
Figure 1. Schematic design of the dual-SPGEs and SEM image of the gold electrodes 
surfaces processes at low temperature (BT) curing inks. Adapted from DropSens [18]. 
 
The RNA aptamer (R3-OPN, described by Mi et al., [17]) and DNA aptamer 
(C10K2, selected and developed by our research group (work under revision)) 
were synthesized by Integrated DNA Technologies (Belgium). Their sequences 
were as follow: RNA aptamer (5’-Biotin- CGG CCA CAG AAU GAA AAA 
CCU CAU CGA UGU UGC AUA GUU G-3’) and DNA aptamer (5’-Biotin-
TGT GTG CGG CAC TCC AGT CTG TTA CGC CGC-3’). Stock solutions of 
DNA and RNA aptamers (100 µM) were prepared with ultra-pure water 
containing 1 % (v/v) of DEPC, to avoid the RNase interference. The working 
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DNA and RNA aptamer solutions were prepared by diluting the stock solutions 
using fresh PBS. The binding recognition between both aptamers and OPN was 
studied by cyclic voltammetry (CV), using a Potentiostat-Galvanostat device 
(PG580, Uniscan Instruments). The pH was measured using a pH meter 
(iHANNA instruments pH 211). The dual-SPGEs were purchased from 
DropSens (Oviedo, Spain). These dual-SPGEs include a four-electrode system 
configuration printed on the same strip of ceramic substrate (3.4 × 1.0 × 0.05 
cm), and were subjected to low temperature (BT) ink curing. The dual-SPGEs 
were composed of two parallel ellipses of gold-BT WE (WE1 and WE2 with a 
surface of 6.3 mm2 each) located at the ceramic strip, an Ag/AgCl reference 
electrode (RE) and a gold-BT counter electrode (CE) (19.8 mm2 and 1 mm 
wide), as shown in Fig. 1. 
 
Immobilization of aptamers onto the dual-SPGEs 
The aptamers’ immobilization onto the dual-SPGE was achieved through the 
streptavidin-biotin interaction, as reported by Meirinho et al. [19]. Fig. 2 shows 
the aptamers’ immobilization onto the two gold WE. First, the  dual-SPGE  was  
cleaned  using  three acid solutions (0.5 M H2SO4, 0.01 M KCl/0.1 M H2SO4 and 
0.05 M H2SO4) under an electric potential, in the range of 0.3 V to +1.5 V, and 
at a scan rate of 100 mV/s. Afterwards, the gold WEs surfaces were modified 
using 200 mM of DPA (30 min at room temperature), 100 mM of EDC and 1 
mM of NHS (1:1 v/v, 60 min at room temperature), 1 mg/mL of streptavidin 
(overnight at 4 ºC), and 100 mM of ETA (20 min at room temperature). Finally, 
the biotinylated aptamers were immobilized onto the gold WE. A solution of 
each biotinylated aptamer (DNA and RNA, 4 nM) prepared in PBS buffer (pH 
7.4) was subjected to a temperature treatment (95 ºC during 5 min, 4 ºC for 5 min 
and 10 min at room temperature) to obtain adequate suitable structure flexibility 
of the aptamers, allowing their interaction with the streptavidin on the gold 
electrode surface. After this pre-treatment step, the DNA aptamer and RNA 
aptamer were incubated into the WE1 and WE2, respectively, during 40 min at 
room temperature, being bound to the surface through the streptavidin-biotin 
interaction.  
 
 
Figure 2. Immobilization of aptamers onto the dual-SPGE. 
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Evaluation of the aptasensor array specificity towards OPN 
The aptasensors array performances, concerning the rhOPN detection, as well as 
their specificities, were evaluated by CV assays. For the detection of rhOPN, the 
dual-SPGE modified with DNA aptamer (WE1) and RNA aptamer (WE2) were 
incubated with 10 µL of an rhOPN solution (200 nM) during 60 min at room 
temperature. To remove the non-specifically bound protein, the electrodes 
surfaces were washed with PBS buffer. The specificity of the arrays was 
evaluated using individual non-specific proteins (BSA, THR, LYS and rbOPN) 
instead of rhOPN, in the detection experiments with dual-SPGE. This approach 
has been previously reported [20, 21]. The aptasensors array response towards 
non-specific binding proteins was assessed using different dual-SPGE modified 
with DNA aptamer and RNA aptamer into the WE1 and WE2, respectively, 
which were incubated under the same experimental conditions tested for rhOPN 
(i.e. 10 µL of each interfering protein solution at 200 nM).  
 
Electrochemical measurements 
In all CV measurements, 100 µL of the [Fe(CN)6]
3−/4−
solution (redox probe) were 
applied on the electrochemical reaction area of the dual-SPGE electrode. The CV 
measurements were performed under a potential range of 0.5 V to + 0.8 V, and 
at a scan rate of 50 mV/s. The decrease in the peak current intensities was 
expressed as relative current change (∆I %). The ∆I % was calculated 
considering the current values of the cyclic voltammogram oxidation peak 
recorded after aptamer immobilization and protein incubation, by using the 
equation (1): 
 
∆I %= (I0 - I1)/I0 x 100 (1) 
 
where ∆I is the relative current change (%); I0 and I1 represent the current before 
and after the sample incubation, respectively. 
 
 
Results and discussion  
Characterization of the dual-SPGE 
The purpose of this work was to develop an electrochemical aptasensor array to 
detect rhOPN simultaneously using two different aptamers (RNA and DNA 
aptamers). The experimental conditions were previously established by Meirinho 
et al. [19]. Hence, the aptamer concentration to immobilize it onto the gold WE 
(WE1 and WE2) and the incubation time for the aptamer-rhOPN interaction were 
fixed at 4 nM and 60 min, respectively. The steps followed during the aptasensor 
array construction and electrode surface functionalization were monitored by 
CV. This electrochemical technique is simple and sensitive, allowing to acquire 
information concerning the reversibility of the oxidation and reduction 
mechanisms that occur at the electrode surface [22]. As an example, Fig. 3 
illustrates the electrochemical characterization of the aptasensor array, namely: 
the cyclic voltamograms recorded for the bare Au electrode; the cleaning 
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procedure with acid solution; t and the aptamer immobilization and aptamer-
rhOPN binding step, for both aptamers. The current responses obtained for the 
bare Au electrode in both gold WE (WE1 and WE2) were almost null. The 
almost absence of the current response, and the observation of a quasi-reversible 
redox peak in the presence of [Fe(CN)6]
3−/4−
, used as the redox probe, could be 
attributed to the fact that these electrodes were exposed to a low temperature 
(BT) curing ink process during their production. After the cleaning step with 
different H2SO4 solutions, characteristic quasi-reversible voltammograms were 
obtained for both gold WE, demonstrating that this step was essential for the 
activation of the gold WE’ surfaces (WE1 and WE2), allowing to obtain a 
uniform and functionalized surface. 
 
 
Figure 3. Cyclic voltammograms of the bare Au electrode, surface cleaning and 
aptamers’ immobilization steps for DNA aptamer (WE1) and RNA aptamer (WE2), 
using a dual-SPGEs. 
 
The step corresponding to the RNA and DNA aptamers immobilization onto the 
gold working surfaces showed a decrease of the peak current intensities 
compared to the cleaning step. This decrease may probably be attributed to the 
negative charges of the aptamers backbone phosphate group and the 
[Fe(CN)6]
3−/4−
 redox probe, resulting in electrostatic repulsive interactions that 
could block the electron transfer [23]. Finally, these results suggest that both 
aptamers were successfully assembled onto the gold working surface. 
 
Evaluation of the aptasensor array performance 
The aptasensors array developed for the simultaneous detection of rhOPN was 
electrochemically evaluated. After the rhOPN incubation (during 60 min onto the 
dual-SPGE modified) with the DNA aptamer (WE1) and the RNA aptamer 
(WE2), significant changes of the voltammograms were observed in comparison 
with the voltammograms recorded after the aptamers’ immobilization, which 
could be due to the change of the aptamer conformation upon protein binding 
(Fig. 4).  
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Figure 4. Cyclic voltammograms after detection of human OPN for DNA aptamer 
(WE1) and RNA aptamer (WE2), using a dual-SPGEs. 
 
The specific recognition of RNA and DNA aptamers led to the formation of the 
aptamer-rhOPN complexes, and similar decreases in the current were observed 
for both gold WE: ∆I (%) of 20% ± 3% for the DNA aptamer-rhOPN and ∆I (%) 
of 19% ± 2% for the RNA aptamer-rhOPN. These values are within the same 
order of magnitude as those obtained in the single analyte aptasensor for RNA 
aptamer [18] and for DNA aptamer [21]. The aptasensors array exhibited a good 
response for rhOPN, with a negative readout signal upon protein binding to 
aptamer (i.e. a signal-off sensing mechanism). The observed signal decrease 
could be even enhanced if several parameters were optimized during the 
aptasensors’ array design. Indeed, it is known that several factors could affect the 
sensitivity and selectivity of the aptasensors, namely the surface of the electrode 
(e.g. composition and area), bioreceptors characteristics (e.g. sequence length, 
experimental conditions isolation/selection) and the experimental conditions used 
to develop the biosensor (e.g. used buffer, incubation temperature and time used 
for the aptamers immobilization, as well as each aptamer concentration to 
immobilize  it onto the electrode surface). However, in this study, the used 
experimental conditions were the ones previously optimized for a gold WE with 
a much lower surface area (0.5 mm2) [19], which could have conditioned the 
overall performance herein reported.  
The specificity of the electrochemical response of the dual-aptasensors array 
(DNA and RNA immobilized aptamers) was evaluated through the response to 
the presence of non-specific proteins (Fig. 5).  
The relative current response (∆I %) for the tested non-specific proteins was 
found to be negligible compared to the binding response obtained for rhOPN, 
with the exception of rbOPN protein. However, since this protein is from animal 
origin, it is not expected to be present in human biological samples, so this 
interference does not represent a real concern. Furthermore, the results clearly 
demonstrated that the dual-aptasensors array may be an interesting 
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complementary tool to detect rhOPN in biological samples, such as blood, 
plasma or serum.  
 
 
Figure 5. Current relative change (∆I %) to rhOPN and non-specific proteins (200 nM); 
THR– Thrombin, BSA – bovine serum albumin, rbOPN – bovine osteopontin and LYS 
– lysozyme, using the dual-SPGE.  
 
 
Conclusions 
This study reports the evaluation of a label-free, signal-off aptasensors array for 
the simultaneous detection of human OPN, which was designed and developed 
using a dual-SPGE. The results herein reported showed that the dual aptasensors 
device possesses a good response and selectivity for human OPN. Despite these 
preliminary encouraging results, the optimization of the aptasensors array for the 
simultaneous detection of human OPN and/or other protein biomarkers, using 
different aptamers immobilized onto the electrode array, is required. Finally, the 
aptasensor performance with synthetic and real biological samples should be 
evaluated. 
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